See All Slides - tctmd.com

Slides

Presentation TCT 2013

3D Bioprinting: The Unlimited Potential of Automated Tissue Engineering Processes

Presenter: Daniel B. Spoon

October 28, 2013

Presentation TCT 2013

Case 5: Acute Myocardial Infarction Due to Vein Graft Occlusion: Tips and Tricks

Presenter: Karel Koch

October 31, 2013

Presentation TCT 2013

A Patient with a Recent Stent Who is Bleeding

Presenter: Peter Wenaweser

October 31, 2013

Presentation TCT 2013

Case #3: How to Treat an Onion Bulb Shape Coronary Lesion

Presenter: Dhaker Lahidheb

October 31, 2013

Presentation TCT 2013

Case Vignettes: Tips and Tricks for Coronary Wire Protection for TAVR

Presenter: Raj Makkar

October 31, 2013

Presentation

Real-world Application: The Importance of Side Branch Preservation

Presenter: Indulis Kumsars

October 31, 2013

Presentation

How New Designs Lead to Improved Clinical Results in TAVR

Presenter: Ganesh Manoharan

October 31, 2013

Presentation TCT 2013

No: They Are Expensive, Entail Risk, and There Is No Evidence of Benefit!

Presenter: Holger Thiele

October 31, 2013

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

How Strong Is the Clinical Data for Pre- and Postconditioning?

Presenter: Thomas Engstr?m

October 31, 2013

Advertisement

Slides

3D Bioprinting: The Unlimited Potential of Automated Tissue Engineering Processes

Case 5: Acute Myocardial Infarction Due to Vein Graft Occlusion: Tips and Tricks

A Patient with a Recent Stent Who is Bleeding

Case #3: How to Treat an Onion Bulb Shape Coronary Lesion

Case Vignettes: Tips and Tricks for Coronary Wire Protection for TAVR

Real-world Application: The Importance of Side Branch Preservation

How New Designs Lead to Improved Clinical Results in TAVR

No: They Are Expensive, Entail Risk, and There Is No Evidence of Benefit!

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

How Strong Is the Clinical Data for Pre- and Postconditioning?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content